Cary Street Partners’s Rayonier RYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$768K Buy
36,091
+4,745
+15% +$99.4K 0.02% 559
2026
Q1
$646K Buy
31,346
+1,850
+6% +$40.8K 0.02% 539
2025
Q4
$639K Sell
29,496
-233
-0.8% -$5.27K 0.02% 542
2025
Q3
$752K Buy
29,729
+535
+2% +$12.8K 0.02% 487
2025
Q2
$617K Buy
29,194
+18,968
+185% +$433K 0.02% 509
2025
Q1
$272K Buy
+10,226
New +$259K 0.01% 672

Other funds holding RYN

Cary Street Partners's RYN Position: Q2 2026 in Review

Cary Street Partners increased its Rayonier (RYN) stake by 15% in Q2 2026, buying an estimated $99.4K and bringing the position to 36,091 shares worth $768K. The position accounts for 0.02% of the portfolio, ranked #559.

Cary Street Partners first reported a position in RYN in Q1 2025 and has held it in 6 quarters since. 457 funds tracked by Wall St. Rank hold RYN as of Q2 2026.

  • Cary Street Partners held 36,091 shares of Rayonier worth $768K as of Q2 2026.
  • Cary Street Partners bought 4,745 Rayonier shares in Q2 2026, an estimated $99.4K.
  • Rayonier made up 0.02% of Cary Street Partners's portfolio in Q2 2026, its #559 holding.
  • Cary Street Partners first reported a position in Rayonier in Q1 2025 and has held it in 6 quarters since.
  • 457 funds tracked by Wall St. Rank held Rayonier as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.